Sector Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Biotechnology & Medical Research

Delayed Hong Kong S.E. Other stock markets 09:29:59 11/02/2026 am IST			5-day change	1st Jan Change
105.00 ^HKD	-0.66%		+4.06%	-7.08%

06/02	Akeso, Inc. Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer	CI
03/02	Akeso granted exclusive commercialization rights for ebronucimab injection to Jumpcan Pharmaceutical	RE

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	P/E
AKESO, INC.	1.2TCr	-
ARGENX SE	5.11TCr
WUXI APPTEC CO., LTD.	4.26TCr
INSMED INCORPORATED	3.19TCr	-
BIONTECH SE	2.77TCr	-
WUXI BIOLOGICS (CAYMAN) INC.	2.02TCr